Toggle light / dark theme

Researchers at MIT have developed a noninvasive medical monitoring device powerful enough to detect single cells within blood vessels, yet small enough to wear like a wristwatch. One important aspect of this wearable device is that it can enable continuous monitoring of circulating cells in the human body. The technology was reported in npj Biosensing.

The device—named CircTrek—was developed by researchers in the Nano-Cybernetic Biotrek research group, led by Deblina Sarkar, assistant professor at MIT and AT&T Career Development Chair at the MIT Media Lab. This technology could greatly facilitate early diagnosis of disease, detection of disease relapse, assessment of infection risk, and determination of whether a disease treatment is working, among other medical processes.

Whereas traditional blood tests are like a snapshot of a patient’s condition, CircTrek was designed to present real-time assessment, referred to in the npj Biosensing paper as having been “an unmet goal to date.” A different technology that offers monitoring of cells in the bloodstream with some continuity, in vivo flow cytometry, “requires a room-sized microscope, and patients need to be there for a long time,” says Kyuho Jang, a Ph.D. student in Sarkar’s lab.

Artificial intelligence (AI) shows tremendous promise for analyzing vast medical imaging datasets and identifying patterns that may be missed by human observers. AI-assisted interpretation of brain scans may help improve care for children with brain tumors called gliomas, which are typically treatable but vary in risk of recurrence.

Investigators from Mass General Brigham and collaborators at Boston Children’s Hospital and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center trained deep learning algorithms to analyze sequential, post-treatment brain scans and flag patients at risk of cancer recurrence.

Their results are published in NEJM AI.

Irritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions. They have in common that they are triggered by an excessive immune response—which in severe cases can be life-threatening.

A team of researchers led by the University of Bonn has now identified a promising bioactive compound that could effectively reduce symptoms and slash fatality risk. The compound blocks a receptor on certain defense cells, thus preventing a derailed immune response. The study findings have been published in the journal Signal Transduction and Targeted Therapy.

If you have ever been bitten by a mosquito, you will know how annoying the resulting itching can be. This is in large part due to mast cells— found in the skin and that are full of inflammatory messengers. When a person is bitten, antibodies bind to substances in the mosquito’s saliva, and this complex can activate the mast cells, which then release their payload all at once. This leads to the symptoms of redness, swelling and itching, which usually subside after a short while, or even quicker, using the right ointment.

The Tesla robotaxi service, as stated, would be a significant leap in capability from what is currently available.

In a new Nature Communications study, researchers have developed an in-memory ferroelectric differentiator capable of performing calculations directly in the memory without requiring a separate processor.

The proposed differentiator promises energy efficiency, especially for edge devices like smartphones, autonomous vehicles, and security cameras.

Traditional approaches to tasks like image processing and motion detection involve multi-step energy-intensive processes. This begins with recording data, which is transmitted to a , which further transmits the data to a microcontroller unit to perform differential operations.

Building GPT-4 took a lot of people. Now, OpenAI says it could rebuild it with as few as five people, all because of what it learned from its latest model, GPT-4.5.

Andreessen Horowitz’s Anjney Midha argues that the US has no choice in terms of how it approaches the artificial intelligence race with China: “We must win.”

Speaking with Semafor’s Reed Albergotti at Semafor’s World Economy Summit on Wednesday, Midha, who is a general partner at the Silicon Valley venture capital firm, said that US AI companies should double down on driving growth rather than stifle innovation over concerns of potentially harmful use cases. People all over the world will choose to use American AI tools, so long as they’re the best available.

“This is why a billion people in India still use WhatsApp. It was invented in Silicon Valley,” Midha said.